|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,086.00 ILa | -1.99% |
|
-1.00% | -0.73% |
| Market Cap | 124M 12.4B 40.6M 35.15M 32.73M 30.08M 56.85M 3.87B 57.69M 386M 151M 1.93B 152M 149M 6.39B | P/E 2024 |
24.5x | P/E 2025 | -6.91x |
|---|---|---|---|---|---|
| Enterprise Value | 252M 25.2B 82.54M 71.45M 66.52M 61.14M 116M 7.87B 117M 785M 308M 3.92B 310M 303M 12.99B | EV / Sales 2024 |
0.87x | EV / Sales 2025 | 0.84x |
| Free-Float |
17.21% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -1.99% | ||
| 1 week | -1.00% | ||
| 1 month | -0.73% | ||
| 3 months | -4.40% | ||
| 6 months | -7.57% | ||
| Current year | -0.73% |
| 1 week | 1,062 |  | 1,144 |
| 1 month | 1,006 | | 1,144 |
| Current year | 1,006 | | 1,348 |
| 1 year | 1,006 | | 1,348 |
| 3 years | 1,006 | | 1,788 |
| 5 years | 1,006 | | 2,610 |
| 10 years | 1,006 | | 4,076 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 82 | 1993-08-23 | |
Yuval Bernshtein
DFI | Director of Finance/CFO | 46 | 2018-10-31 |
| President | 80 | 2010-06-27 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 82 | 2010-06-24 | |
| Director/Board Member | 80 | - | |
Avraham Bigger
CHM | Chairman | 80 | 2015-04-14 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.99% | -1.00% | -8.66% | -31.87% | 40.43M | |
| -1.08% | +1.82% | +22.52% | +111.39% | 100B | |
| +1.30% | +0.88% | +47.46% | +151.01% | 53.87B | |
| -0.68% | +3.52% | +2.80% | +274.52% | 23.74B | |
| +0.60% | +2.93% | -12.64% | -16.12% | 8.37B | |
| -1.29% | +1.85% | -33.43% | -30.57% | 7.56B | |
| -1.53% | +3.21% | -7.75% | -30.20% | 6.92B | |
| -1.14% | -1.47% | +23.29% | +22.85% | 6.16B | |
| -1.83% | -0.87% | -0.52% | +22.61% | 5.29B | |
| -.--% | +2.79% | -6.02% | -3.62% | 3.8B | |
| Average | -0.76% | +1.08% | +2.70% | +47.00% | 21.6B | |
| Weighted average by Cap. | -0.40% | +1.64% | +21.23% | +118.01% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 322M 32.17B 105M 91.23M 84.93M 78.06M 148M 10.05B 150M 1B 393M 5B 396M 387M 16.59B | 301M 30.1B 98.59M 85.35M 79.46M 73.03M 138M 9.4B 140M 938M 367M 4.68B 370M 362M 15.52B |
| Net income | 6.21M 621M 2.03M 1.76M 1.64M 1.51M 2.85M 194M 2.89M 19.33M 7.57M 96.54M 7.63M 7.47M 320M | -18.07M -1.81B -5.92M -5.13M -4.77M -4.39M -8.29M -565M -8.41M -56.3M -22.06M -281M -22.23M -21.74M -932M |
| Net Debt | 127M 12.71B 41.63M 36.04M 33.55M 30.84M 58.28M 3.97B 59.14M 396M 155M 1.98B 156M 153M 6.55B | 128M 12.8B 41.93M 36.3M 33.79M 31.06M 58.71M 4B 59.57M 399M 156M 1.99B 157M 154M 6.6B |
Employees
390
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-31 | ILA 1,086.00 | -1.99% | 3,403 |
| 26-07-30 | ILA 1,108.00 | +1.47% | 9,576 |
| 26-07-29 | ILA 1,092.00 | +1.30% | 95 |
| 26-07-28 | ILA 1,078.00 | +0.94% | 1,207 |
| 26-07-27 | ILA 1,068.00 | -2.64% | 1,114 |
- Stock Market
- Stocks
- REKA Stock
Select your edition
All financial news and data tailored to specific country editions
